title: [Chemotherapy of liver abscess (II). Significance of the preoperative administration of amphotericin B based on concentration in the liver tissue].
authors.forename: H
authors.initials: H
authors.lastname: Tanimura
authors.forename: K
authors.initials: K
authors.lastname: Tabuse
authors.forename: K
authors.initials: K
authors.lastname: Mori
authors.forename: N
authors.initials: N
authors.lastname: Shimotsuma
authors.forename: Y
authors.initials: Y
authors.lastname: Kasano
authors.forename: M
authors.initials: M
authors.lastname: Ochiai
authors.forename: K
authors.initials: K
authors.lastname: Yoshida
authors.forename: N
authors.initials: N
authors.lastname: Kobayashi
authors.forename: Y
authors.initials: Y
authors.lastname: Yamaoka
authors.forename: Y
authors.initials: Y
authors.lastname: Shimahara
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001646:Bile / Q000378:metabolism; D005260:Female; D005704:Gallbladder / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000378:metabolism*; D008100:Liver Abscess / Q000188:drug therapy* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy / Q000517:prevention & control; D011292:Premedication; D013154:Spleen / Q000378:metabolism; D014018:Tissue Distribution
chemical_list: D000666:Amphotericin B